This cohort study examines the prevalence of and factors associated with glucagon-like peptide 1 agonist discontinuation among new users.
No takes yet. Share an insight, caveat, or question.
Ngoc et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: